Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression.
about
A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cellsEmerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatologyCardiac biomarkers: new tools for heart failure managementLipocalin 2 (LCN2) Expression in Hepatic Malfunction and TherapyCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityNFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 genePulmonary effects of inhaled diesel exhaust in young and old mice: a pilot projectNo effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancerA role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis.Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.Lipocalin 2 is protective against E. coli pneumonia.Evaluation of the optimal neutrophil gelatinase-associated lipocalin value as a screening biomarker for urinary tract infections in children.Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.The different molecular forms of urine neutrophil gelatinase-associated lipocalin present in dogs with urinary diseasesMicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity.Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2Iron, lipocalin, and kidney epithelia.Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses.Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice.The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerUpregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasionLipocalin 2: a multifaceted modulator of human cancer.Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) StudyNeutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor?Regulation of neutrophil gelatinase-associated lipocalin expression by C/EBPβ in lung carcinoma cells.Mechanistic biomarkers for cytotoxic acute kidney injury.Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression.The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.Expression of neutrophil gelatinase-associated lipocalin in calcium-induced keratinocyte differentiation.The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cellsIron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster.Correlation of Urine and Serum Biomarkers with Renal Damage and Survival in Dogs with Naturally Occurring Proteinuric Chronic Kidney Disease.Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer
P2860
Q24294493-455CB07B-7E49-4D01-807A-2DE723C5754AQ26829452-CCD111E2-5737-4F91-AFEF-000F282EA4D4Q26991726-8BE34AC9-115A-4FFB-ABC4-595274E91296Q28068137-9E4DFE6D-7270-4AE5-8EC4-9BB07E2E5500Q28081407-9B2EAE46-3D19-47C1-8BFE-DFEFD778A8EDQ28271428-3CA22946-E650-45CB-997E-37D0B2B108E1Q28387892-2C4DB167-02D7-4A45-92E7-5C8EF929C9E9Q28480579-4A2B6FBC-839D-4212-B89E-F67D48EE77B3Q30384899-F4EAEEF8-69E9-47E4-AB4E-EE51B83602DAQ31042613-4D5F42BA-5D17-47B2-895B-4CFA529916C9Q31048088-5B797A0B-F5A8-4CAB-A9AE-B28B843CB647Q33510912-17B7AF7D-04C2-457A-A459-5055F03E0F2EQ33514944-BA1694B2-C5EA-4DE2-BAF3-27C5F20C9B03Q33688934-CDA2AA90-951B-4CE6-BB88-9F390BF76F19Q33754152-0EE37581-CB54-4DF5-BC47-45A37E67313DQ33969500-27F8AFB9-3182-4BA8-9CA9-781B3DBAE4AEQ34028908-884547B2-E64C-4A74-80EB-6EE7A512CF7DQ34116619-C11CB08F-5936-4F44-8112-6C3518DD02A8Q34440998-D61F9B1C-B843-4B09-8226-D84D9FAE7D6DQ34539539-B64C1C77-8E0D-466D-9C9D-73B2D372EF9EQ34541482-F4923713-8BFA-45D5-8AB3-25D57123BE19Q35139278-8D1325C5-3C2F-464A-9313-3ECC6101B1F0Q35146299-229C5E68-1957-4294-8EA1-7586CC361A4CQ35589239-725518E3-8091-4B63-95C5-81D4D6377FD0Q35854126-529E960A-5DCE-461C-A183-01C17FBE61D3Q35908335-FC16D8E3-C1A9-482D-9902-851AAD272BA8Q35996059-6938B231-1DF7-4289-8995-C82AB0BE8655Q36014333-F8CB49CF-784B-4946-888B-39FF4734EA79Q36054255-76B2C308-8D61-4D4D-9378-E6F91C21B1C8Q36103565-17DA8D08-2AE0-413B-AD5A-83132DE539C3Q36142609-7B9DF050-F725-439E-BBBA-94F957924CB0Q36403421-EBF407C8-DB09-43D6-8564-BAE17C91840BQ36609753-8A91C15D-8AD6-4F26-BD16-E5BEECA66B7FQ36676377-6824DF31-B2E7-44D8-8AF6-86AFCEBAD5FEQ36762507-DC926BEB-18CB-4A14-B9E9-C673BA2C1B10Q36854138-0F9D13B8-38BA-468E-93EE-740B12B1A580Q36893682-D28257C7-B303-43DA-807C-A01D5A13AFC8Q36917365-D7F77E20-64C2-4846-842F-EF1DE24CABB6Q37020310-FB90DCA3-9DD3-4110-8B16-7F982C26EC71Q37099888-C0013CAD-9D83-46ED-AF35-135DF0CA9E85
P2860
Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@ast
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@en
type
label
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@ast
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@en
prefLabel
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@ast
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@en
P2093
P356
P1476
Neutrophil gelatinase-associat ...... pecific pattern of expression.
@en
P2093
P304
P356
10.1023/A:1003708808934
P577
1999-07-01T00:00:00Z